Journal article
A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia
Abstract
Eleven patients with acute non-lymphocytic leukemia and persistent leukemia on a bone marrow done 6 days after the start of standard induction chemotherapy with daunorubicin and cytosine arabinoside were given augmentation chemotherapy with carboplatin as a continuous intravenous infusion over 3 days. Nine of the 11 patients (82%) entered complete remission. The hematologic and non-hematologic toxicities encountered by these patients were …
Authors
Benger AM; Browman GP; Walker IR; Meyer RM; Wilson WEC; McBride JA
Journal
Leukemia Research, Vol. 16, No. 2, pp. 159–163
Publisher
Elsevier
Publication Date
2 1992
DOI
10.1016/0145-2126(92)90127-s
ISSN
0145-2126